Biliary sludge: solved and unresolved issues
https://doi.org/10.21518/2079-701X-2018-14-90-96
Abstract
About the Authors
O. N. MinushkinRussian Federation
E. G. Burdina
Russian Federation
E. V. Novozhenova
Russian Federation
References
1. Ilchenko AA. Gallbladder and bile duct disorders, 2011, 358.
2. Mansurov HH. Gallstone disease, 1991, 222 pages.
3. Ilchenko AA. Gallstone disease classification. Rossiyskiy Zhurnal Gastroenterologii, Gepatologii, Koloproktologii, 2002, 5, p. 99.
4. Minushkin ON, Burdina EG, Novozhenova EV. Biliary Sludge. Epidemiology, risk factors for formation, diagnosis, treatment approaches. Meditsinskiy Alfavit, 19, 2017, 2.
5. Novozhenova EV. Biliary sludge: risk factors, diagnosis, treatment, prognosis, diss. of Ph.D., 2017.
6. Ilchenko AA, Delyukina OV. Clinical significance of biliary sludge. Journal Consilium Medicum, 2005, 2, 28-32.
7. Minushkin ON, et al. Biliary Sludge: diagnosis and treatment in outpatient clinic settings. Journal Eksperimentalnaya i Klinicheskaya Gastroenterologiya, 2013, 9, 14-20.
8. Maev IV, et al. Immediacy of the therapy of patients with biliary sludge. Journal Klinicheskiye Perspektivy Gastroenterologii, Gepatologii, 2013, 1, 3-10
9. Vikhrova ТV. Biliary sludge and its clinical significance. Extended abstract of PhD in medicine Dissertation. Moscow, 2003.
10. Minushkin ON, et al. The hepatopathy and the role of Laennec in the treatment. Methodical guide, 2017, 11 pp.
11. Minushkin ON, Elizavetina GA, Ivanova OI, Shaposhnikova OF. Ursodeoxycholic acid in the treatment of patients with biliary sludge, Journal Effektivnaya Farmakoterapiya, 2012, 3, p. 10-13.
Review
For citations:
Minushkin ON, Burdina EG, Novozhenova EV. Biliary sludge: solved and unresolved issues. Meditsinskiy sovet = Medical Council. 2018;(14):90-96. (In Russ.) https://doi.org/10.21518/2079-701X-2018-14-90-96